Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have been given an average rating of “Buy” by the nine analysts that are covering the firm, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]

Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the nine ratings firms that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average […]

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has received an average rating of “Buy” from the fourteen brokerages that are presently covering the stock, Marketbeat.com reports. Fourteen equities research analysts have rated the stock with a buy rating. The average 12 month target price among analysts that have covered the stock in the last […]

Shares of AXT, Inc. (NASDAQ:AXTI – Get Free Report) have been given an average recommendation of “Buy” by the five brokerages that are currently covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have issued ratings on the stock […]

Shares of HealthStream, Inc. (NASDAQ:HSTM – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five analysts that are presently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has assigned a strong buy recommendation […]

Shares of Surge Energy Inc. (TSE:SGY – Get Free Report) have been given an average rating of “Buy” by the four brokerages that are presently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]